Latest astrocytoma Stories
Pilocytic astrocytoma (PA) is the most common pediatric brain tumor, and there are few medical therapies available to those patients for whom surgery is not curative.
A detailed analysis of gene fusions present at high frequency in the most common pediatric brain tumors has been performed for the first time.
For patients with glioma, the most common primary brain tumor, new findings may explain why current therapies fail to eradicate the cancer.
TUSTIN, Calif., Feb. 11 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc.
Missing, mutated genes occur simultaneously in unique set of pediatric brain tumors.
There was no substantial change in brain tumor incidence among adults 5 to 10 years after cell phone usage sharply increased.
TUSTIN, Calif., Dec. 2 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today reported completion of patient enrollment in a dose confirmation and dosimetry trial of CotaraÂ® in patients with relapsed glioblastoma multiforme (GBM), the deadliest form of brain cancer.
BOSTON, Mass. and TUSTIN, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc.
Malignant brain tumors often fail to respond to promising new medication. Researchers in Heidelberg have discovered a mechanism and a tumor marker for the development of this resistance.
- A hairdresser.